Klotho Therapeutics, Inc.
PrivateLast Round
Series A
Nov 2, 2017
Total Funding Raised
$10M
Company Overview
Klotho Therapeutics, Inc. is a biotechnology company that develops patent-pending recombinant versions of the human Klotho protein to treat age-related diseases such as kidney disease, cognitive decline, and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Klotho Therapeutics, Inc. Comparables
Compare Klotho Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jocasta Neuroscience | 85% | |
| ADvantage Therapeutics Inc. | 83% | |
| Elevian | 79% |
Klotho Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 2, 2017 |
Klotho Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Thynk Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
Monthly visitors increased 51% MoM.
- Nov 12, 2024
Monthly visitors grew 136% MoM, reaching 5.2K.
Klotho Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Klotho Therapeutics, Inc.'s valuation, stock price, and market status.
Is Klotho Therapeutics, Inc. a public or private company?
Klotho Therapeutics, Inc. is a private company.
What is the current stock price of Klotho Therapeutics, Inc.?
Klotho Therapeutics, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Klotho Therapeutics, Inc. worth (valuation)?
Valuation information for Klotho Therapeutics, Inc. is not publicly available.
Can I buy Klotho Therapeutics, Inc. stock?
Klotho Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Klotho Therapeutics, Inc.'s last funding round?
Klotho Therapeutics, Inc.'s most recent funding round was Series A on November 2, 2017.
Who are the main investors in Klotho Therapeutics, Inc.?
Key investors in Klotho Therapeutics, Inc. include Thynk Capital.
Will Klotho Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Klotho Therapeutics, Inc..
How can I track Klotho Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Klotho Therapeutics, Inc.'s secondary market activity and sign up for updates.